Karen Ballen, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002) (NCT05233618) | Karen Ballen, MD | 2022-07-13 |
Track Karen Ballen, MD automatically
Every clearance here is in the API, with alerts when new ones post.